Literature DB >> 4407116

Letter: Levamisole for recurrent herpes labialis.

A Kint, L Verlinden.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4407116     DOI: 10.1056/NEJM197408082910614

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  11 in total

1.  Experimental immunosuppression induced by herpes simplex virus.

Authors:  R Cappel; C Henry; L Thiry
Journal:  Arch Virol       Date:  1975       Impact factor: 2.574

2.  Treatment with levamisole of recurrent herpes genitalis.

Authors:  T W Chang; N Fiumara
Journal:  Antimicrob Agents Chemother       Date:  1978-05       Impact factor: 5.191

3.  Leukocyte migration inhibitory factor in primary and recurrent ocular infections by herpes simplex-virus.

Authors:  G Grabner; R Jarisch
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1979-07-02

Review 4.  Cell-mediated immunity and its role in resistance to infection.

Authors:  E J Wing; J S Remington
Journal:  West J Med       Date:  1977-01

5.  Letter: Treatment of recurrent aphthous stomatitis and herpes with levamisole.

Authors:  J Symoens; J Brugmans
Journal:  Br Med J       Date:  1974-12-07

6.  L-tetramisole. Enhancement of human lymphocyte response to antigen.

Authors:  H F Pabst; J Crawford
Journal:  Clin Exp Immunol       Date:  1975-09       Impact factor: 4.330

7.  Effects of levamisole on normal and abnormal leukocyte locomotion.

Authors:  D G Wright; C H Kirkpatrick; J I Gallin
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

8.  The effect of levamisole on cellular immunity in multiple sclerosis.

Authors:  P C Dau; K P Johnson; L E Spitler
Journal:  Clin Exp Immunol       Date:  1976-11       Impact factor: 4.330

9.  Restoration of methotrexate-suppressed oxazolone-induced contact sensitivity with levamisole.

Authors:  D E Griswold; D T Walz
Journal:  Inflammation       Date:  1978-03       Impact factor: 4.092

10.  Condition-dependent immunoregulatory control of contact sensitivity by levamisole.

Authors:  D E Griswold; D T Walz
Journal:  Inflammation       Date:  1977-12       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.